金信諾(300252.SZ):實控人黃昌華擬協議轉讓1790萬股予高鑫金諾
格隆匯9月13日丨金信諾(300252.SZ)公佈,公司於近日收到公司控股股東、實際控制人黃昌華(“出讓人”或“甲方”)的通知,因其在國泰君安證券股份有限公司(“國泰君安”或“質權人”或“丙方”)的股票質押合約已到期待購回,根據相關通知和規定,2021年8月31日,黃昌華與高鑫金諾及國泰君安對相關股票質押採用協議轉讓方式進行處置事宜及《股份轉讓協議》的條款達成一致,黃昌華通過協議轉讓方式向高鑫金諾轉讓其持有的公司1790萬股無限售流通股,佔公司總股本3.10%,佔回購後公司總股本3.11%。
2021年9月11日,黃昌華與高鑫金諾及國泰君安完成《股份轉讓協議》的簽訂。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.